Hildred Capital Management, LLC (“Hildred”), a lower middle-market healthcare private equity firm, announces the successful final closing of its third fund, Hildred Equity Partners III (the “Fund”). The Fund was significantly oversubscribed, exceeding its $600 million target and hitting its hard cap in seven months. Hildred remains committed to generating strong financial returns for its investors by tapping into secular growth opportunities across a range of subsectors in healthcare products and services, including commercial stage pharmaceutical and OTC products, care delivery services, medical devices, life science tools and diagnostics, outsourced pharmaceutical and clinical services, and healthcare IT and tech enabled services, as well as related businesses.
Read the full article: Hildred Capital Announces Oversubscribed Final Close of Hildred Equity Partners III with Capital Commitments in Excess of $800M //
Source: https://www.businesswire.com/news/home/20250113771166/en/Hildred-Capital-Announces-Oversubscribed-Final-Close-of-Hildred-Equity-Partners-III-with-Capital-Commitments-in-Excess-of-800-Million